Streetbeat News

Analyst Ratings

VRNS

Morgan Stanley analyst Hamza Fodderwala maintains an Overweight rating on Varonis Systems (NASDAQ:VRNS) and raises the price target from $39 to $42.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:09 pm

UDMY

Morgan Stanley analyst Josh Baer has maintained an Equal-Weight rating on Udemy (NASDAQ:UDMY) and raised the price target from $12 to $15.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:08 pm

TMDX

Morgan Stanley analyst Cecilia Furlong maintains an Equal-Weight rating on TransMedics Gr (NASDAQ:TMDX) and raises the price target from $50 to $54.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:06 pm

BP

BX

CPRT

PLTR

SOFI

UEC

Jim Cramer, host of CNBC's 'Mad Money Lightning Round', gave his opinions on several stocks. He recommended Uranium Energy Corp. (UEC), Blackstone Inc. (BX), and SoFi Technologies, Inc. (SOFI), and praised Copart, Inc. (CPRT). He was negative about BP p.l.c. (BP) and had a change of heart about Palantir Technologies Inc. (PLTR), which he said reported a 'dynamite' quarter.

Portfolio Pulse from Lisa Levin

November 07, 2023 | 2:05 pm

TDUP

Morgan Stanley analyst Lauren Schenk has maintained an Equal-Weight rating on ThredUp (NASDAQ:TDUP) and lowered the price target from $4 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:05 pm

TASK

Morgan Stanley analyst James Faucette has maintained an Equal-Weight rating on TaskUs (NASDAQ:TASK) and lowered the price target from $13 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:04 pm

SIBN

Morgan Stanley analyst Drew Ranieri has maintained an Overweight rating on SI-BONE (NASDAQ:SIBN) but lowered the price target from $30 to $25.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:03 pm

SWAV

Morgan Stanley analyst Patrick Wood has maintained an Overweight rating on ShockWave Medical (NASDAQ:SWAV) but lowered the price target from $313 to $284.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:01 pm

CTSH

Cognizant Tech Solns (NASDAQ:CTSH) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 6 indifferent ratings. The average price target is $72.5, indicating potential upside from the current price of $66.28. The average price target has increased by 0.69% over the past month.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 2:00 pm

MRTX

Over the past 3 months, 11 analysts have published their opinion on Mirati Therapeutics (NASDAQ:MRTX) stock. The average price target for the stock is $63.09, with a high of $83.00 and a low of $48.00. The majority of the analysts are indifferent about the stock, with 2 being bullish, 2 somewhat bullish, and 7 indifferent. The average price target has increased by 4.91% over the past month.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 2:00 pm